Par Pharm., Inc. v. Hospira, Inc. ; United States Court of Appeals of the Federal Circuit, 2020; No. 2020-1273, 2020 WL 6846347; (Non-precedential)

Biotechnology Law Report,Volume 40, Issue 2, Page 133-138, April 2021.
Source: Biotechnology Law Report - Category: Medical Law Source Type: research